These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17408462)

  • 1. Cl-IB-MECA inhibits human erythropoiesis.
    Bhanu NV; Aerbajinai W; Gantt NM; Jackson EK; Goh SH; Terry Lee Y; Miller JL
    Br J Haematol; 2007 May; 137(3):233-6. PubMed ID: 17408462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
    Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
    Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
    Kim GD; Oh J; Jeong LS; Lee SK
    Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
    Lu J; Pierron A; Ravid K
    Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.
    Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A
    Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
    Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
    J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
    Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
    Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA.
    Smith SR; Denhardt G; Terminelli C
    Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the A3 adenosine receptor affects cell cycle progression and cell growth.
    Brambilla R; Cattabeni F; Ceruti S; Barbieri D; Franceschi C; Kim YC; Jacobson KA; Klotz KN; Lohse MJ; Abbracchio MP
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):225-34. PubMed ID: 10731034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells.
    Kim H; Kang JW; Lee S; Choi WJ; Jeong LS; Yang Y; Hong JT; Yoon DY
    Anticancer Res; 2010 Jul; 30(7):2823-30. PubMed ID: 20683018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.
    Kim SG; Ravi G; Hoffmann C; Jung YJ; Kim M; Chen A; Jacobson KA
    Biochem Pharmacol; 2002 Mar; 63(5):871-80. PubMed ID: 11911839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
    Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G
    Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
    Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
    Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.
    Aghaei M; Panjehpour M; Karami-Tehrani F; Salami S
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1511-23. PubMed ID: 21830157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.